On ECHEMI
Home > Drugs > Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.

Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.

  • Founded in:

    2011-04-11
  • Country:

    China China
  • Address:

    West side of Yanbin Road, Feixian Economic Development Zone
  • Tax NO.:

    913713255728813685
  • Registered Funds:

    50 million yuan
  • Email:

Related Drugs
Sulbactam sodium
This product is a compound preparation, its components are ampicillin sodium and sulbactam sodium.
Name Description Content CAS NO. Registered Holders
Ampicillin sodium

When used in combination with sulbactam sodium, the MIC of Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, Bacteroides fragilis, etc., which are resistant to penicillins and cephalosporins due to enzyme production, can be reduced to within the sensitive range.

More

When used in combination with sulbactam sodium, the MIC of Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, Bacteroides fragilis, etc., which are resistant to penicillins and cephalosporins due to enzyme production, can be reduced to within the sensitive range.

69-52-3 33
Sulbactam sodium

This product is a semi-synthetic β-lactamase inhibitor. It has strong antibacterial activity against Neisseria gonorrhoeae, Neisseria meningitidis and Acinetobacter calcoaceticus. It has poor effects on other bacteria, but has strong and irreversible competitive inhibition of β-lactamase produced by Staphylococcus aureus and most Gram-negative bacteria. The concentration of 2mg/L has a strong inhibitory effect on Richmond classification type II, III, IV and V β-lactamase, but has a poor effect on type I β-lactamase. This product has a strong affinity for PBP1 of Bacillus thuringiensis and PBP2 of Acinetobacter calcoaceticus.

More

This product is a semi-synthetic β-lactamase inhibitor. It has strong antibacterial activity against Neisseria gonorrhoeae, Neisseria meningitidis and Acinetobacter calcoaceticus. It has poor effects on other bacteria, but has strong and irreversible competitive inhibition of β-lactamase produced by Staphylococcus aureus and most Gram-negative bacteria. The concentration of 2mg/L has a strong inhibitory effect on Richmond classification type II, III, IV and V β-lactamase, but has a poor effect on type I β-lactamase. This product has a strong affinity for PBP1 of Bacillus thuringiensis and PBP2 of Acinetobacter calcoaceticus.

69388-84-7 30
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.